Leonid N Maslov

Prof. Leonid N Maslov

Institute of Cardiology, Tomsk, Tomskaya Oblast’, Russia
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Apoptosis
Verified
Journal Article
Closed access
PDF file
SPSergey V. Popov
Sergey V. Popov
AMAlexander V. Mukhomedzyanov
Alexander V. Mukhomedzyanov
NVNikita S. Voronkov
Nikita S. Voronkov
IDIvan A. Derkachev
Ivan A. Derkachev
ABAlla A. Boshchenko
Alla A. Boshchenko
LMLeonid N Maslov
Leonid N Maslov

8 October 2018 in Current Cardiology Reviews
Verified
Journal Article
Closed access
PDF file
AKAndrey V. Krylatov
Andrey V. Krylatov
LMLeonid N Maslov
Leonid N Maslov
NVNikita S. Voronkov
Nikita S. Voronkov
ABAlla Boshchenko
Alla Boshchenko
SPSergey Popov
Sergey Popov
JDJames M. Downey
James M. Downey
Redox signaling plays an important role in the lives of cells. This signaling not only becomes apparent in pathologies but is also thought to be involved in maintaining physiological homeostasis. Reactive oxygen species (ROS) can activate protein kinases: CaMKII, PKG, PKA, ERK, PI3K, Akt, PKC, PDK, JNK, p38. It is unclear whether it is a direct interaction of ROS with these kinases or whether their activation is a consequence of inhibition of phosphatases. ROS have a biphasic effect on the transport of Ca2+ in the cell: on one hand, they activate the sarcoplasmic reticulum Ca2+-ATPase, which can reduce the level of Ca2+ in the cell, and on the other they can inactivate the Ca2+-ATPase of the plasma membrane and open the cation channels TRPM2, which promotes Ca2+-loading and subsequent apoptosis. ROS inhibit the enzyme PHD2, which leads to the stabilization of HIF-α and the formation of the active transcription factor HIF. Activation of STAT3 and STAT5, induced by cytokines or growth factors, may include activation of NADPH oxidase and enhancement of ROS production. Normal physiological production of ROS under the action of cytokines activates the JAK/STAT while excessive ROS production leads to their inhibition. ROS cause the activation of the transcription factor NF-κB. Physiological levels of ROS control cell proliferation and angiogenesis. ROS signaling is also involved in beneficial adaptations to survive ischemia and hypoxia, while further increases in ROS can trigger programmed cell death by the mechanism of apoptosis or autophagy. ROS formation in the myocardium can be reduced by moderate exercise.

21 January 2015 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MLMeili Lu
Meili Lu
FTFutian Tang
Futian Tang
JZJing Zhang
Jing Zhang
ALAina Luan
Aina Luan
MMMeng Mei
Meng Mei
LMLeonid N Maslov
Leonid N Maslov

1 March 2019 in Journal of Clinical & Translational Endocrinology
Verified
Journal Article
Open access
LMLeonid N Maslov
Leonid N Maslov
Natalia NaryzhnayaNatalia Naryzhnaya
Natalia Naryzhnaya
ABAlla Boshchenko
Alla Boshchenko
SPSergey Popov
Sergey Popov
VIVladimir V. Ivanov
Vladimir V. Ivanov
POPeter R. Oeltgen
Peter R. Oeltgen
Metabolic syndrome is accompanied by oxidative stress in animals and humans. The main source of ROS in experimental metabolic syndrome is NADPH oxidase and possibly adipocyte mitochondria. It is now documented that oxidative stress induces insulin resistance of adipocytes and increases secretion of leptin, MCP-1, IL-6, and TNF-α by adipocytes. It was established that oxidative stress induces a decrease in adiponectin production by adipocytes. It has also been shown that obesity itself can induce oxidative stress. Oxidative stress can cause an alteration of intracellular signaling in adipocytes that apparently leads to the formation of insulin resistance of adipocytes. Chronic stress, glucocorticoids, mineralocorticoids, angiotensin-II, TNF-α also play an important role in the pathogenesis of oxidative stress of adipocytes. Oxidative stress is not only a consequence of metabolic syndrome, but also a reason and a foundational link in the pathogenesis of the metabolic syndrome.

24 February 2009 in Life Sciences
Verified
Journal Article
Closed access
LMLeonid N Maslov
Leonid N Maslov
YLYury B. Lishmanov
Yury B. Lishmanov
POPeter R. Oeltgen
Peter R. Oeltgen
EBEva I. Barzakh
Eva I. Barzakh
AKAndrey V. Krylatov
Andrey V. Krylatov
SBStephen A. Brown
Stephen A. Brown

12 May 2020 in Hormones
Verified
Journal Article
Closed access
PDF file
STSergey Tsibulnikov
Sergey Tsibulnikov
LMLeonid N Maslov
Leonid N Maslov
NVNikita Voronkov
Nikita Voronkov
POPeter Oeltgen
Peter Oeltgen